Bridging the translational innovation gap through good biomarker practice
暂无分享,去创建一个
Barend Mons | Jaap Heringa | Niklas Blomberg | Kurt Zatloukal | Jan-Eric Litton | Andreas Scherer | Marian Hajduch | Gerrit Meijer | Florence Bietrix | Alain J. van Gool | J. Heringa | Jan-Eric Litton | K. Zatloukal | A. Scherer | N. Blomberg | G. Meijer | B. Mons | E. Caldenhoven | A. V. Gool | Eric Caldenhoven | Andy Smith | Wim-Jan Koot | Martin J. Smit | Ton Rijnders | Anton Ussi | F. Bietrix | Ton Rijnders | A. Ussi | M. Hajdůch | Andy Smith | Wim-Jan Koot
[1] Erik Schultes,et al. The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.
[2] Andreas Busch,et al. Industry–academia collaborations for biomarkers , 2015, Nature Reviews Drug Discovery.
[3] Christopher P. Austin,et al. Putting translational science on to a global stage , 2016, Nature Reviews Drug Discovery.
[4] I. Cockburn,et al. The Economics of Reproducibility in Preclinical Research , 2015, PLoS biology.
[5] J. Cuzick,et al. Assessing opportunities for coordinated R&D in early cancer detection and management in Europe , 2016, International journal of cancer.